MTRI

Mentari Therapeutics, Inc. - Common Stock (MTRI)

About Mentari Therapeutics, Inc. - Common Stock (MTRI)

Mentari Therapeutics, Inc. is a biotechnology company, which engages in developing therapies for migraine prevention. Its portfolio includes MT-001 and MT-002. The company was founded on June 13, 2025 and is headquartered in Waltham, MA.

Details

Daily high
$18.12
Daily low
$14.98
Price at open
$18.12
52 Week High
$23.30
52 Week Low
$5.75
Market cap
9.6M
Dividend yield
-
Volume
13,955
Avg. volume
34,230
P/E ratio
-.56

Mentari Therapeutics, Inc. - Common Stock News

Details

Daily high
$18.12
Daily low
$14.98
Price at open
$18.12
52 Week High
$23.30
52 Week Low
$5.75
Market cap
9.6M
Dividend yield
-
Volume
13,955
Avg. volume
34,230
P/E ratio
-.56